ICAAC 2005

Vaccine for Enterotoxigenic E. coli – Travelers’ Diarrhoea

Louis Bourgeois, Johns Hopkins University, Baltimore
Among the various experiences when visiting a developing country: there’s amazement at the sounds and the colour; delight at the warmth of the people and the climate; but also, unfortunately, travelers’ diarrhea. But the main causal bacterium, enterotoxigenic E. coli – or ETEC – is also responsible for a large amount of morbidity and mortality among children who live in the developing world. So, interest was stoked at ICAAC by the possibility of an oral killed vaccine for travellers’ diarrhea which has now been used in a double blind, randomised study involving 1400 people.

Click here for all the interviews from ICAAC 2005

Similar Interviews

  • Non-Perfect HIV Vaccine Could Still Have Major Benefits
  • ANTHONY FAUCI, National Institutes of Health, Bethesda REFERENCE: N Engl J Med 2007;356:2073-81 Is there any hope for an HIV vaccine? According

  • Audio Journal of Infectious Disease - Vaccine to Save Marburg Virus Infected Patients Lives?">Audio Journal of Infectious Disease - Vaccine to Save Marburg Virus Infected Patients Lives?
  • Thomas Geisbert, US Army Medical Research, Institute of Infectious Diseases, Fort Detrick REFERENCE: Lancet 2006;367:1399 April 29th, 2006-05-26 A vaccine developed against

  • Chloroquine Selects for Fluoroquinolone Resistance in Guyana
  • Ross Davidson Ross Davidson, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia The use of the antimalarial chloroquine could provide the

    Post a comment

    Subscribe to Audio Medica Podcast